Option Care Health, Inc. (OPCH)
USD 22.78
(-2.73%)
USD 22.78
(-2.73%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.16 Billion USD | 7.64% |
| 2022 | 1.08 Billion USD | 2.23% |
| 2021 | 1.05 Billion USD | -4.95% |
| 2020 | 1.11 Billion USD | -12.69% |
| 2019 | 1.27 Billion USD | 153.08% |
| 2018 | 504.67 Million USD | 5.01% |
| 2017 | 480.58 Million USD | 6.34% |
| 2016 | 451.93 Million USD | 4.14% |
| 2015 | 433.98 Million USD | 2.4% |
| 2014 | 423.8 Million USD | -2.7% |
| 2013 | 435.57 Million USD | 92.41% |
| 2012 | 226.37 Million USD | -22.86% |
| 2011 | 293.45 Million USD | -4.25% |
| 2010 | 306.46 Million USD | 833.62% |
| 2009 | 32.82 Million USD | -34.88% |
| 2008 | 50.41 Million USD | 49.24% |
| 2007 | 33.77 Million USD | -36.14% |
| 2006 | 52.89 Million USD | 612.2% |
| 2005 | 7.42 Million USD | 1.21% |
| 2004 | 7.33 Million USD | 1590.78% |
| 2003 | 434 Thousand USD | -92.36% |
| 2002 | 5.67 Million USD | 249.48% |
| 2001 | 1.62 Million USD | -31.67% |
| 2000 | 2.37 Million USD | -40.61% |
| 1999 | 4 Million USD | -45.15% |
| 1998 | 7.3 Million USD | 630.0% |
| 1997 | 1 Million USD | 66.67% |
| 1996 | 600 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.22 Billion USD | 4.68% |
| 2024 Q3 | 1.11 Billion USD | -0.32% |
| 2024 Q1 | 1.17 Billion USD | 0.37% |
| 2023 FY | 1.16 Billion USD | 7.64% |
| 2023 Q1 | 1.05 Billion USD | -2.38% |
| 2023 Q4 | 1.16 Billion USD | 10.35% |
| 2023 Q3 | 1.05 Billion USD | -0.04% |
| 2023 Q2 | 1.05 Billion USD | -0.04% |
| 2022 Q1 | 1.15 Billion USD | 9.41% |
| 2022 FY | 1.08 Billion USD | 2.23% |
| 2022 Q2 | 1.15 Billion USD | -0.19% |
| 2022 Q4 | 1.08 Billion USD | -6.24% |
| 2022 Q3 | 1.15 Billion USD | -0.14% |
| 2021 Q3 | 1.22 Billion USD | 0.07% |
| 2021 Q1 | 1.22 Billion USD | 9.41% |
| 2021 FY | 1.05 Billion USD | -4.95% |
| 2021 Q4 | 1.05 Billion USD | -13.14% |
| 2021 Q2 | 1.21 Billion USD | -0.06% |
| 2020 Q2 | 1.35 Billion USD | -0.41% |
| 2020 Q1 | 1.35 Billion USD | 6.44% |
| 2020 Q3 | 1.16 Billion USD | -14.11% |
| 2020 FY | 1.11 Billion USD | -12.69% |
| 2020 Q4 | 1.11 Billion USD | -4.1% |
| 2019 Q1 | 535.8 Million USD | 6.17% |
| 2019 FY | 1.27 Billion USD | 153.08% |
| 2019 Q3 | 1.35 Billion USD | 145.6% |
| 2019 Q2 | 549.82 Million USD | 2.62% |
| 2019 Q4 | 1.27 Billion USD | -5.41% |
| 2018 FY | 504.67 Million USD | 5.01% |
| 2018 Q4 | 504.67 Million USD | 1.17% |
| 2018 Q1 | 481.43 Million USD | 0.18% |
| 2018 Q2 | 493.26 Million USD | 2.46% |
| 2018 Q3 | 498.84 Million USD | 1.13% |
| 2017 Q2 | 477.4 Million USD | 1.04% |
| 2017 Q4 | 480.58 Million USD | 0.42% |
| 2017 Q1 | 472.49 Million USD | 4.55% |
| 2017 FY | 480.58 Million USD | 6.34% |
| 2017 Q3 | 478.58 Million USD | 0.25% |
| 2016 FY | 451.93 Million USD | 4.14% |
| 2016 Q1 | 423.93 Million USD | -2.32% |
| 2016 Q4 | 451.93 Million USD | 3.6% |
| 2016 Q3 | 436.24 Million USD | 9.21% |
| 2016 Q2 | 399.45 Million USD | -5.77% |
| 2015 Q2 | 418.85 Million USD | 0.01% |
| 2015 Q1 | 418.82 Million USD | -1.17% |
| 2015 FY | 433.98 Million USD | 2.4% |
| 2015 Q4 | 433.98 Million USD | -3.33% |
| 2015 Q3 | 448.91 Million USD | 7.18% |
| 2014 Q3 | 423.28 Million USD | 1.08% |
| 2014 Q1 | 418.66 Million USD | -3.88% |
| 2014 Q4 | 423.8 Million USD | 0.12% |
| 2014 FY | 423.8 Million USD | -2.7% |
| 2014 Q2 | 418.74 Million USD | 0.02% |
| 2013 Q2 | 225.49 Million USD | -11.0% |
| 2013 Q3 | 415.6 Million USD | 84.31% |
| 2013 FY | 435.57 Million USD | 92.41% |
| 2013 Q1 | 253.36 Million USD | 11.92% |
| 2013 Q4 | 435.57 Million USD | 4.81% |
| 2012 Q4 | 226.37 Million USD | -0.03% |
| 2012 Q1 | 291.37 Million USD | -0.71% |
| 2012 FY | 226.37 Million USD | -22.86% |
| 2012 Q2 | 257.44 Million USD | -11.64% |
| 2012 Q3 | 226.44 Million USD | -12.04% |
| 2011 FY | 293.45 Million USD | -4.25% |
| 2011 Q4 | 293.45 Million USD | 5.21% |
| 2011 Q3 | 278.92 Million USD | 2.05% |
| 2011 Q2 | 273.31 Million USD | -1.56% |
| 2011 Q1 | 277.63 Million USD | -9.41% |
| 2010 Q2 | 321.2 Million USD | -3.7% |
| 2010 Q4 | 306.46 Million USD | -3.81% |
| 2010 Q3 | 318.61 Million USD | -0.81% |
| 2010 FY | 306.46 Million USD | 833.62% |
| 2010 Q1 | 333.54 Million USD | 916.11% |
| 2009 Q2 | 33.06 Million USD | -8.44% |
| 2009 Q1 | 36.11 Million USD | -28.36% |
| 2009 Q4 | 32.82 Million USD | -17.07% |
| 2009 FY | 32.82 Million USD | -34.88% |
| 2009 Q3 | 39.58 Million USD | 19.71% |
| 2008 Q2 | 19.81 Million USD | -59.16% |
| 2008 Q3 | 55.02 Million USD | 177.74% |
| 2008 Q4 | 50.41 Million USD | -8.38% |
| 2008 FY | 50.41 Million USD | 49.24% |
| 2008 Q1 | 48.5 Million USD | 43.61% |
| 2007 Q4 | 33.77 Million USD | -6.58% |
| 2007 Q3 | 36.15 Million USD | -13.63% |
| 2007 Q2 | 41.86 Million USD | -16.58% |
| 2007 Q1 | 50.18 Million USD | -5.12% |
| 2007 FY | 33.77 Million USD | -36.14% |
| 2006 FY | 52.89 Million USD | 612.2% |
| 2006 Q2 | 38.17 Million USD | 26.32% |
| 2006 Q3 | 45.58 Million USD | 19.42% |
| 2006 Q1 | 30.21 Million USD | 306.87% |
| 2006 Q4 | 52.89 Million USD | 16.04% |
| 2005 Q3 | 14.41 Million USD | 25.01% |
| 2005 Q4 | 7.42 Million USD | -48.46% |
| 2005 Q2 | 11.52 Million USD | 645.18% |
| 2005 Q1 | 1.54 Million USD | -78.92% |
| 2005 FY | 7.42 Million USD | 1.21% |
| 2004 FY | 7.33 Million USD | 1590.78% |
| 2004 Q3 | 8.3 Million USD | -23.25% |
| 2004 Q2 | 10.82 Million USD | -28.37% |
| 2004 Q1 | 15.1 Million USD | 3381.11% |
| 2004 Q4 | 7.33 Million USD | -11.65% |
| 2003 FY | 434 Thousand USD | -92.36% |
| 2003 Q4 | 434 Thousand USD | -24.91% |
| 2003 Q1 | 1.58 Million USD | -72.18% |
| 2003 Q2 | 744 Thousand USD | -52.91% |
| 2003 Q3 | 578 Thousand USD | -22.31% |
| 2002 FY | 5.67 Million USD | 249.48% |
| 2002 Q3 | 6.81 Million USD | -47.79% |
| 2002 Q2 | 13.05 Million USD | -35.36% |
| 2002 Q4 | 5.67 Million USD | -16.67% |
| 2002 Q1 | 20.19 Million USD | 1142.65% |
| 2001 Q4 | 1.62 Million USD | -7.93% |
| 2001 Q2 | 1.94 Million USD | -10.12% |
| 2001 Q1 | 2.16 Million USD | -9.04% |
| 2001 FY | 1.62 Million USD | -31.67% |
| 2001 Q3 | 1.76 Million USD | -9.21% |
| 2000 Q4 | 2.37 Million USD | -57.79% |
| 2000 Q1 | 2.54 Million USD | -36.36% |
| 2000 Q2 | 4.05 Million USD | 59.18% |
| 2000 Q3 | 5.63 Million USD | 38.91% |
| 2000 FY | 2.37 Million USD | -40.61% |
| 1999 FY | 4 Million USD | -45.15% |
| 1999 Q2 | 2.6 Million USD | -33.33% |
| 1999 Q3 | 3.7 Million USD | 42.31% |
| 1999 Q4 | 4 Million USD | 8.22% |
| 1999 Q1 | 3.9 Million USD | -46.58% |
| 1998 Q4 | 7.3 Million USD | 37.74% |
| 1998 Q3 | 5.3 Million USD | 562.5% |
| 1998 FY | 7.3 Million USD | 630.0% |
| 1998 Q1 | 900 Thousand USD | -10.0% |
| 1998 Q2 | 800 Thousand USD | -11.11% |
| 1997 Q1 | 500 Thousand USD | -16.67% |
| 1997 Q3 | 400 Thousand USD | -20.0% |
| 1997 Q4 | 1 Million USD | 150.0% |
| 1997 FY | 1 Million USD | 66.67% |
| 1997 Q2 | 500 Thousand USD | 0.0% |
| 1996 Q3 | 600 Thousand USD | 0.0% |
| 1996 FY | 600 Thousand USD | 0.0% |
| 1996 Q4 | 600 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.51 Billion USD | 22.791% |
| Addus HomeCare Corporation | 175.18 Million USD | -565.829% |
| AirSculpt Technologies, Inc. | 99.66 Million USD | -1070.297% |
| Amedisys, Inc. | 487.21 Million USD | -139.405% |
| American Oncology Network, Inc. | 128.32 Million USD | -808.951% |
| Astrana Health, Inc. | 321.01 Million USD | -263.352% |
| Aveanna Healthcare Holdings Inc. | 1.49 Billion USD | 22.197% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 114.87 Million USD | -915.41% |
| Cryo-Cell International, Inc. | 10.89 Million USD | -10604.926% |
| Cross Country Healthcare, Inc. | 5.26 Million USD | -22045.662% |
| COMPASS Pathways plc | 33.04 Million USD | -3429.235% |
| DocGo Inc. | 46.49 Million USD | -2408.567% |
| The Ensign Group, Inc. | 1.87 Billion USD | 37.668% |
| Healthcare Services Group, Inc. | 43.63 Million USD | -2573.111% |
| InnovAge Holding Corp. | 113.03 Million USD | -931.903% |
| Assure Holdings Corp. | 14.8 Million USD | -7778.501% |
| The Joint Corp. | 16.73 Million USD | -6869.965% |
| LifeStance Health Group, Inc. | 511.04 Million USD | -128.242% |
| Mobile-health Network Solutions Class A Ordinary Shares | 657.13 Thousand USD | -177400.141% |
| ModivCare Inc. | 1.14 Billion USD | -2.311% |
| NewGenIvf Group Limited | 332.55 Thousand USD | -350644.693% |
| Novo Integrated Sciences, Inc. | 4.47 Million USD | -25984.605% |
| P3 Health Partners Inc. | 124.64 Million USD | -835.817% |
| P3 Health Partners Inc. | 124.64 Million USD | -835.817% |
| The Pennant Group, Inc. | 329.63 Million USD | -253.853% |
| Surgery Partners, Inc. | 3.06 Billion USD | 61.902% |
| Syra Health Corp. Class A Common Stock | 248.1 Thousand USD | -470032.163% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 119.81 Million USD | -873.511% |
| The Oncology Institute, Inc. | 119.81 Million USD | -873.511% |